0
Other Articles |

THE TREATMENT OF PULMONARY TUBERCULOSIS WITH SULFAPYRIDINE

STANTON T. ALLISON, M.D.; ROBERT MYERS, M.D.
JAMA. 1939;113(18):1631-1634. doi:10.1001/jama.1939.02800430023006.
Text Size: A A A
Published online

The encouraging results of sulfanilamide therapy in infections caused by the hemolytic streptococcus, the meningococcus, the colon bacillus and the gonococcus, and the more recent results of sulfapyridine therapy in pneumococcic pneumonia have made us hopeful that eventually some such chemotherapeutic agent might be discovered which would influence the course of pulmonary tuberculosis in a favorable manner. The reports from England as well as those from America have indicated that sulfapyridine is an impressive drug, powerful in effecting a cure in pneumonia yet relatively nontoxic as far as permanent harm or death of the patient is concerned. We felt that this drug might have some bactericidal effect on the tubercle bacillus, and since there had been no reports on its use in treating tuberculosis we decided in December 1938 on the investigation which we are now reporting. Recently there has appeared in the literature a paper on the effects of

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();